Table 3 Critical appraisal using Joanna Briggs Institute (JBI) tool for prevalence studies
From: Epidemiology and burden of progressive familial intrahepatic cholestasis: a systematic review
| Â | Agarwal, 2016[61] | Arnell, 2008[48] | Aydogdu, 2007[49] | Bull, 2018[58] | Chen, 2018[63] | Dinler, 1999[54] | Emond, 1995[50] | Englert, 2007[38] | Erginel, 2018[64] |
|---|---|---|---|---|---|---|---|---|---|
Was the sample frame appropriate to address the target population? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Unclear |
Were study participants sampled in an appropriate way? | Yes | Yes | Yes | Yes | Yes | Unclear | Yes | Unclear | Unclear |
Was the sample size adequate? | NA | NA | NA | NA | NA | NA | NA | NA | NA |
Were the study subjects and the setting described in detail? | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes |
Were valid methods used for the identification of the condition? | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Unclear | Yes |
Was the condition measured in a standard, reliable way for all participants? | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Unclear | Yes |
Was there appropriate statistical analysis? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NA | Yes |
Was the response rate adequate, and if not, was the low response rate managed appropriately? | NA | NA | NA | NA | NA | NA | NA | NA | NA |